|
Volumn 10, Issue 1, 2008, Pages 31-34
|
Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: An open-label study
a,b c d e f g h h i j k l m n o p q r s t more.. |
Author keywords
Antiepileptic drug; Myoclonic seizures; Progressive myoclonic epilepsy; Zonisamide
|
Indexed keywords
CLONAZEPAM;
DIAZEPAM;
LAMOTRIGINE;
LORAZEPAM;
VALPROIC ACID;
ZONISAMIDE;
ADD ON THERAPY;
ADJUVANT THERAPY;
ADOLESCENT;
ADULT;
ANOREXIA;
ARTICLE;
ASTHENIA;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CONVULSION;
DECREASED APPETITE;
DRUG DOSE INCREASE;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
LIVER FUNCTION;
MALE;
MULTICENTER STUDY;
MULTIPLE ORGAN FAILURE;
MYOCLONUS EPILEPSY;
MYOCLONUS SEIZURE;
NERVOUSNESS;
OPEN STUDY;
OUTCOME ASSESSMENT;
PATIENT COMPLIANCE;
PHASE 4 CLINICAL TRIAL;
PRIORITY JOURNAL;
SIDE EFFECT;
SOMNOLENCE;
THERAPY RESISTANCE;
TREMOR;
ADOLESCENT;
ADULT;
ANTICONVULSANTS;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
ISOXAZOLES;
MALE;
MYOCLONIC EPILEPSIES, PROGRESSIVE;
SEIZURES;
|
EID: 41949083860
PISSN: 12949361
EISSN: None
Source Type: Journal
DOI: 10.1684/epd.2008.0168 Document Type: Article |
Times cited : (38)
|
References (8)
|